...
首页> 外文期刊>Movement disorders >Serum from Sydenham's chorea patients modifies intracellular calcium levels in PC12 cells by a complement-independent mechanism.
【24h】

Serum from Sydenham's chorea patients modifies intracellular calcium levels in PC12 cells by a complement-independent mechanism.

机译:Sydenham舞蹈病患者的血清通过非补体依赖性机制改变PC12细胞的细胞内钙水平。

获取原文
获取原文并翻译 | 示例
           

摘要

The proposed pathogenesis of Sydenham's chorea (SC) is an autoantibody-mediated basal ganglia dysfunction. Our study has shown that incubation of PC12 cells with complement-inactivated serum from SC patients was associated with a significant increase in Ca2+ levels evoked by KCl stimulus (mean +/- SEM, 341.0 +/- 8.7% of fluorescence intensity, arbitrary units) when compared with incubation with control serum (313.8 +/- 8.7% of fluorescence intensity, arbitrary units; P = 0.01). The increase in Ca2+ levels determined by SC patients sera correlated directly with the enzyme-linked immunosorbent assay optical density values for anti-basal ganglia antibodies. Our study supports the hypothesis that antibodies against basal ganglia in SC may cause their dysfunction.
机译:Sydenham舞蹈病(SC)的发病机理是一种自身抗体介导的基底神经节功能障碍。我们的研究表明,将PC12细胞与SC患者的补体灭活血清一起温育与KCl刺激引起的Ca2 +水平显着增加有关(平均+/- SEM,荧光强度为341.0 +/- 8.7%,任意单位)与对照血清温育(荧光强度的313.8 +/- 8.7%,任意单位; P = 0.01)相比。由SC患者血清确定的Ca2 +水平的增加与抗基底节抗体的酶联免疫吸附测定光密度值直接相关。我们的研究支持以下假设:SC中针对基底神经节的抗体可能会导致其功能障碍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号